Skip to main content
Integrity IndexIntegrity Index
← Companies
IOVA

IOVANCE BIOTHERAPEUTICS, INC.

Data as of Oct 10, 2026
IOVA
CIK 1425205Biological Products, (No Diagnostic Substances)
Federal contracts since 2024
$613K
4 awards · latest Jan 10, 2026

Federal contracts

$612,942 in federal contract awards across 4 actions since January 2024, most recently Jan 10, 2026. Amounts are obligated values as reported to USAspending; modifications and de-obligations can be negative.

By agency

  • Department of Veterans Affairs$613K4 awards

Largest awards

DateAwardAmount
Jan 10, 2026
Department of Veterans Affairs
AMTAGVI
$393,366
Apr 4, 2025
Department of Veterans Affairs
PROLEUKIN 22ML
$219,576
Oct 2, 2024
Department of Veterans Affairs
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
$0
Apr 17, 2024
Department of Veterans Affairs
INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS
$0

Data: FEC (PAC contributions, Schedule A), Quiver Quantitative (congressional holdings, lobbying, contracts), Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to IOVANCE BIOTHERAPEUTICS, INC. through its SEC registration (CIK 1425205) and tickers IOVA.

As of: contract actions through Jan 10, 2026. Snapshot rebuilt Oct 10, 2026.

Holdings values are estimates from disclosed ranges. PAC contributions cover the current and previous election cycle and count only gifts to sitting members' principal campaign committees, so leadership PACs and losing candidates are not included.